Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...
Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage trial are ...
Hosted on MSN
Catnap is not a monster (cartoon animation)
After a containment breach unleashes Catnap into the Playtime Co. factory, Player is attacked! The vicious Catnap is trying to protect his Smiling Critter friends from the evil CEO. Dogday, Bubba ...
IMDb.com, Inc. n'assume aucune responsabilité quant au contenu ou à l'exactitude des articles de presse, des tweets ou des billets de blogue susmentionnés. Ce contenu est publié uniquement dans le but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback